The Top 5 Biosimilar Articles for the Week of December 16
Number 5: The impact of pharmaceutical companies' evergreening strategies on the adoption of trastuzumab biosimilars in the Netherlands led to significant price reductions and increased market share. Number 4: A real-world study in France found patient …